Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma

Activating mutations involving the members of the RAS signaling pathway, including KRAS, NRAS, and BRAF, have been reported in ovarian low-grade serous carcinoma and its precursor lesion, serous borderline tumor (SBT). Whether additional genetic alterations in the RAS oncogene family accumulate duri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Pathol
Main Authors: Xing, Deyin, Rahmanto, Yohan Suryo, Zeppernick, Felix, Hannibal, Charlotte G., Kjaer, Susanne K., Vang, Russell, Shih, Ie-Ming, Wang, Tian-Li
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5696063/
https://ncbi.nlm.nih.gov/pubmed/28873354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.humpath.2017.08.021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados